Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne C Levy

Showing results (111-120 of 164) with videos related to

Pageof 17
Sort By:
Circulation|October 18, 2012
Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillatorRobert W Rho, Kristen K Patton, Jeanne E Poole, et al.
Circulation. Heart Failure|May 4, 2017
Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients)David E Lanfear, Wayne C Levy, Josef Stehlik, et al.
BMJ Supportive & Palliative Care|December 8, 2018
Utility of the Seattle Heart Failure Model for palliative care referral in advanced ambulatory heart failureNicholas Ng Fat Hing, Jane MacIver, Derrick Chan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 6, 2015
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failureTodd Dardas, Yanhong Li, Shelby D Reed, et al.
European Journal of Heart Failure|January 24, 2009
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trialsWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
ESC Heart Failure|May 28, 2021
Cost-effectiveness of left ventricular assist devices as destination therapy in the United KingdomStephan Schueler, Scott C Silvestry, William G Cotts, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 21, 2017
Pulmonary function tests do not predict mortality in patients undergoing continuous-flow left ventricular assist device implantationEdo K S Bedzra, Todd F Dardas, Richard K Cheng, et al.
Journal of the American College of Cardiology|January 24, 2009
Utility of the Seattle Heart Failure Model in patients with advanced heart failureAndreas P Kalogeropoulos, Vasiliki V Georgiopoulou, Grigorios Giamouzis, et al.
JACC. Clinical Electrophysiology|May 30, 2017
Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?Wayne C Levy, Yanhong Li, Shelby D Reed, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 31, 2019
Prognostic usefulness of planar <sup>123</sup>I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: Follow-Up data from ADMIRE-HFDenis Agostini, Karthikeyan Ananthasubramaniam, Harish Chandna, et al.
Pageof 17

Showing results (111-120 of 164) with videos related to

Sort By:
Pageof 17
Circulation|October 18, 2012
Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillatorRobert W Rho, Kristen K Patton, Jeanne E Poole, et al.
Circulation. Heart Failure|May 4, 2017
Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients)David E Lanfear, Wayne C Levy, Josef Stehlik, et al.
BMJ Supportive & Palliative Care|December 8, 2018
Utility of the Seattle Heart Failure Model for palliative care referral in advanced ambulatory heart failureNicholas Ng Fat Hing, Jane MacIver, Derrick Chan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 6, 2015
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failureTodd Dardas, Yanhong Li, Shelby D Reed, et al.
European Journal of Heart Failure|January 24, 2009
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trialsWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
ESC Heart Failure|May 28, 2021
Cost-effectiveness of left ventricular assist devices as destination therapy in the United KingdomStephan Schueler, Scott C Silvestry, William G Cotts, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 21, 2017
Pulmonary function tests do not predict mortality in patients undergoing continuous-flow left ventricular assist device implantationEdo K S Bedzra, Todd F Dardas, Richard K Cheng, et al.
Journal of the American College of Cardiology|January 24, 2009
Utility of the Seattle Heart Failure Model in patients with advanced heart failureAndreas P Kalogeropoulos, Vasiliki V Georgiopoulou, Grigorios Giamouzis, et al.
JACC. Clinical Electrophysiology|May 30, 2017
Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?Wayne C Levy, Yanhong Li, Shelby D Reed, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 31, 2019
Prognostic usefulness of planar <sup>123</sup>I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: Follow-Up data from ADMIRE-HFDenis Agostini, Karthikeyan Ananthasubramaniam, Harish Chandna, et al.
Pageof 17